323 related articles for article (PubMed ID: 10702407)
21. Galectin-8: a matricellular lectin with key roles in angiogenesis.
Troncoso MF; Ferragut F; Bacigalupo ML; Cárdenas Delgado VM; Nugnes LG; Gentilini L; Laderach D; Wolfenstein-Todel C; Compagno D; Rabinovich GA; Elola MT
Glycobiology; 2014 Oct; 24(10):907-14. PubMed ID: 24939370
[TBL] [Abstract][Full Text] [Related]
22. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.
Schnaper HW; Grant DS; Stetler-Stevenson WG; Fridman R; D'Orazi G; Murphy AN; Bird RE; Hoythya M; Fuerst TR; French DL
J Cell Physiol; 1993 Aug; 156(2):235-46. PubMed ID: 8344982
[TBL] [Abstract][Full Text] [Related]
23. Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia.
Ebos JM; Tran J; Master Z; Dumont D; Melo JV; Buchdunger E; Kerbel RS
Mol Cancer Res; 2002 Dec; 1(2):89-95. PubMed ID: 12496355
[TBL] [Abstract][Full Text] [Related]
24. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
[TBL] [Abstract][Full Text] [Related]
25. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
26. Tumor cells secrete an angiogenic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endothelial cells.
Peverali FA; Mandriota SJ; Ciana P; Marelli R; Quax P; Rifkin DB; Della Valle G; Mignatti P
J Cell Physiol; 1994 Oct; 161(1):1-14. PubMed ID: 7523424
[TBL] [Abstract][Full Text] [Related]
27. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
28. Transglutaminase-mediated oligomerization of galectin-3 modulates human melanoma cell interactions with laminin.
van den Brûle FA; Liu FT; Castronovo V
Cell Adhes Commun; 1998 Sep; 5(6):425-35. PubMed ID: 9791724
[TBL] [Abstract][Full Text] [Related]
29. Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer.
Nangia-Makker P; Wang Y; Raz T; Tait L; Balan V; Hogan V; Raz A
Int J Cancer; 2010 Dec; 127(11):2530-41. PubMed ID: 20162566
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells.
Honjo Y; Nangia-Makker P; Inohara H; Raz A
Clin Cancer Res; 2001 Mar; 7(3):661-8. PubMed ID: 11297262
[TBL] [Abstract][Full Text] [Related]
31. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
Chuang CH; Liu CH; Lu TJ; Hu ML
Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
[TBL] [Abstract][Full Text] [Related]
32. Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH 3T3 cells.
Castle VP; Dixit VM; Polverini PJ
Lab Invest; 1997 Jul; 77(1):51-61. PubMed ID: 9251678
[TBL] [Abstract][Full Text] [Related]
33. Suramin inhibits C6 glioma-induced angiogenesis in vitro.
Coomber BL
J Cell Biochem; 1995 Jun; 58(2):199-207. PubMed ID: 7545684
[TBL] [Abstract][Full Text] [Related]
34. Requirement of the nuclear localization of transcription enhancer factor 3 for proliferation, migration, tube formation, and angiogenesis induced by vascular endothelial growth factor.
Liu X; Zhao D; James L; Li J; Zeng H
FASEB J; 2011 Apr; 25(4):1188-97. PubMed ID: 21169383
[TBL] [Abstract][Full Text] [Related]
35. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen.
Shekhar MP; Werdell J; Tait L
Cancer Res; 2000 Jan; 60(2):439-49. PubMed ID: 10667599
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy.
Benelli R; Adatia R; Ensoli B; Stetler-Stevenson WG; Santi L; Albini A
Oncol Res; 1994; 6(6):251-7. PubMed ID: 7532474
[TBL] [Abstract][Full Text] [Related]
37. A secreted type of beta 1,6-N-acetylglucosaminyltransferase V (GnT-V) induces tumor angiogenesis without mediation of glycosylation: a novel function of GnT-V distinct from the original glycosyltransferase activity.
Saito T; Miyoshi E; Sasai K; Nakano N; Eguchi H; Honke K; Taniguchi N
J Biol Chem; 2002 May; 277(19):17002-8. PubMed ID: 11872751
[TBL] [Abstract][Full Text] [Related]
38. Alpha4beta1 integrin mediates selective endothelial cell responses to thrombospondins 1 and 2 in vitro and modulates angiogenesis in vivo.
Calzada MJ; Zhou L; Sipes JM; Zhang J; Krutzsch HC; Iruela-Arispe ML; Annis DS; Mosher DF; Roberts DD
Circ Res; 2004 Mar; 94(4):462-70. PubMed ID: 14699013
[TBL] [Abstract][Full Text] [Related]
39. Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo.
Riccioni T; Cirielli C; Wang X; Passaniti A; Capogrossi MC
Gene Ther; 1998 Jun; 5(6):747-54. PubMed ID: 9747454
[TBL] [Abstract][Full Text] [Related]
40. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.
Clapp C; Martial JA; Guzman RC; Rentier-Delure F; Weiner RI
Endocrinology; 1993 Sep; 133(3):1292-9. PubMed ID: 7689950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
